documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

1,990 rows where docket_id = "FDA-2007-D-0369" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_month, open_for_comment, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

posted_year 20

document_type 3

agency_id 1

id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2007-D-0369-2428 FDA None FDA-2007-D-0369 Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability Notice Notice of Availability 2026-02-27T05:00:00Z 2026 2 2026-02-27T05:00:00Z   2026-02-27T19:14:17Z 2026-03963 0 0 09000064b91e3271
FDA-2007-D-0369-2444 FDA None FDA-2007-D-0369 PSG_020151 - Draft Guidance on Venlafaxine Hydrochloride Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:22:37   1 0 09000064b91df4e6
FDA-2007-D-0369-2442 FDA None FDA-2007-D-0369 PSG_020144 - Draft Guidance on Nitroglycerin Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:21:57   1 0 09000064b91df4d8
FDA-2007-D-0369-2432 FDA None FDA-2007-D-0369 PSG_018084 - Draft Guidance on Tolmetin Sodium Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:18:51   1 0 09000064b91df465
FDA-2007-D-0369-2457 FDA None FDA-2007-D-0369 PSG_021336 - Draft Guidance on Selegiline Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:26:39   1 0 09000064b91e011b
FDA-2007-D-0369-2440 FDA None FDA-2007-D-0369 PSG_019982 - Draft Guidance on Bisoprolol Fumarate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:21:21   1 0 09000064b91df4d4
FDA-2007-D-0369-2447 FDA None FDA-2007-D-0369 PSG_020375 - Draft Guidance on Estradiol Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:23:38   1 0 09000064b91df4f2
FDA-2007-D-0369-2459 FDA None FDA-2007-D-0369 PSG_021427 - Draft Guidance on Duloxetine Hydrochloride Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:27:37   1 0 09000064b91e011f
FDA-2007-D-0369-2461 FDA None FDA-2007-D-0369 PSG_021514 - Draft Guidance on Methylphenidate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:29:28   1 0 09000064b91e0123
FDA-2007-D-0369-2438 FDA None FDA-2007-D-0369 PSG_019813 - Draft Guidance on Fentanyl Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:20:47   1 0 09000064b91df4d0
FDA-2007-D-0369-2464 FDA None FDA-2007-D-0369 PSG_021829 - Draft Guidance on Rotigotine Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:30:54   1 0 09000064b91e0129
FDA-2007-D-0369-2497 FDA None FDA-2007-D-0369 PSG_213224 - Draft Guidance on Octreotide acetate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:42:17   1 0 09000064b91e018a
FDA-2007-D-0369-2490 FDA None FDA-2007-D-0369 PSG_211843 - Draft Guidance on Tiopronin Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:39:55   1 0 09000064b91e0172
FDA-2007-D-0369-2475 FDA None FDA-2007-D-0369 PSG_202211 - Draft Guidance on Oxybutynin Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:35:11   1 0 09000064b91e0140
FDA-2007-D-0369-2466 FDA None FDA-2007-D-0369 PSG_022029 - Draft Guidance on Menthol; Methyl Salicylate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:31:54   1 0 09000064b91e012d
FDA-2007-D-0369-2467 FDA None FDA-2007-D-0369 PSG_022083 - Draft Guidance on Rivastigmine Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:32:28   1 0 09000064b91e012f
FDA-2007-D-0369-2520 FDA None FDA-2007-D-0369 PSG_218466 - Draft Guidance on Alpelisib Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:50:12   1 0 09000064b91e01d3
FDA-2007-D-0369-2511 FDA None FDA-2007-D-0369 PSG_216352 - Draft Guidance on Paliperidone Palmitate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:47:03   1 0 09000064b91e01b4
FDA-2007-D-0369-2512 FDA None FDA-2007-D-0369 PSG_216665 - Draft Guidance on Diazoxide Choline Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:47:20   1 0 09000064b91e01b6
FDA-2007-D-0369-2508 FDA None FDA-2007-D-0369 PSG_215431 - Draft Guidance on Meloxicam; Rizatriptan Benzoate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:46:07   1 0 09000064b91e01ad
FDA-2007-D-0369-2481 FDA None FDA-2007-D-0369 PSG_207620 - Draft Guidance on Sacubitril; Valsartan Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:37:17   1 0 09000064b91e0156
FDA-2007-D-0369-2489 FDA None FDA-2007-D-0369 PSG_211733 - Draft Guidance on Acetaminophen; Ibuprofen Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:39:39   1 0 09000064b91e0170
FDA-2007-D-0369-2479 FDA None FDA-2007-D-0369 PSG_206089 - Draft Guidance on Testosterone Undecanoate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:36:31   1 0 09000064b91e0152
FDA-2007-D-0369-2469 FDA None FDA-2007-D-0369 PSG_022264 - Draft Guidance on Paliperidone Palmitate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:33:09   1 0 09000064b91e0133
FDA-2007-D-0369-2473 FDA None FDA-2007-D-0369 PSG_085635 - Draft Guidance on Testosterone Cypionate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:34:27   1 0 09000064b91e013c
FDA-2007-D-0369-2488 FDA None FDA-2007-D-0369 PSG_210868 - Draft Guidance on Lorlatinib Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:39:21   1 0 09000064b91e016e
FDA-2007-D-0369-2486 FDA None FDA-2007-D-0369 PSG_209310 - Draft Guidance on Mometasone Furoate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:38:46   1 0 09000064b91e016a
FDA-2007-D-0369-2506 FDA None FDA-2007-D-0369 PSG_215401 - Draft Guidance on Dextroamphetamine Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:45:23   1 0 09000064b91e01a9
FDA-2007-D-0369-2522 FDA None FDA-2007-D-0369 PSG_218585 - Draft Guidance on Aceclidine Hydrochloride Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:51:02   1 0 09000064b91e01d7
FDA-2007-D-0369-2509 FDA None FDA-2007-D-0369 PSG_215602 - Draft Guidance on Baclofen Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:46:21   1 0 09000064b91e01af
FDA-2007-D-0369-2516 FDA None FDA-2007-D-0369 PSG_217225 - Draft Guidance on Avacincaptad Pegol Sodium Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:48:56   1 0 09000064b91e01cb
FDA-2007-D-0369-2507 FDA None FDA-2007-D-0369 PSG_215429 - Draft Guidance on Venlafaxine Besylate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:45:49   1 0 09000064b91e01ab
FDA-2007-D-0369-2443 FDA None FDA-2007-D-0369 PSG_020145 - Draft Guidance on Nitroglycerin Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:22:16   1 0 09000064b91df4da
FDA-2007-D-0369-2460 FDA None FDA-2007-D-0369 PSG_021447 - Draft Guidance on Tizanidine Hydrochloride Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:27:59   1 0 09000064b91e0121
FDA-2007-D-0369-2446 FDA None FDA-2007-D-0369 PSG_020357 - Draft Guidance on Metformin Hydrochloride Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:23:14   1 0 09000064b91df4f0
FDA-2007-D-0369-2448 FDA None FDA-2007-D-0369 PSG_020489 - Draft Guidance on Testosterone Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:23:57   1 0 09000064b91df4f4
FDA-2007-D-0369-2454 FDA None FDA-2007-D-0369 PSG_021234 - Draft Guidance on Diclofenac Epolamine Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:25:35   1 0 09000064b91e010a
FDA-2007-D-0369-2500 FDA None FDA-2007-D-0369 PSG_214410 - Draft Guidance on Baloxavir Marboxil Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:43:31   1 0 09000064b91e0190
FDA-2007-D-0369-2494 FDA None FDA-2007-D-0369 PSG_212516 - Draft Guidance on Duloxetine Hydrochloride Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:41:20   1 0 09000064b91e0184
FDA-2007-D-0369-2484 FDA None FDA-2007-D-0369 PSG_208143 - Draft Guidance on Barium Sulfate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:38:13   1 0 09000064b91e015c
FDA-2007-D-0369-2495 FDA None FDA-2007-D-0369 PSG_212526 - Draft Guidance on Alpelisib Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:41:39   1 0 09000064b91e0186
FDA-2007-D-0369-2476 FDA None FDA-2007-D-0369 PSG_203479 - Draft Guidance on Clozapine Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:35:30   1 0 09000064b91e014c
FDA-2007-D-0369-2482 FDA None FDA-2007-D-0369 PSG_207962 - Draft Guidance on Lidocaine Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:37:34   1 0 09000064b91e0158
FDA-2007-D-0369-2480 FDA None FDA-2007-D-0369 PSG_206968 - Draft Guidance on Acetaminophen Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:36:59   1 0 09000064b91e0154
FDA-2007-D-0369-2429 FDA None FDA-2007-D-0369 PSG_012283 - Draft Guidance on Chlorthalidone Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:17:46   1 0 09000064b91df45f
FDA-2007-D-0369-2441 FDA None FDA-2007-D-0369 PSG_020076 - Draft Guidance on Nicotine Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:21:38   1 0 09000064b91df4d6
FDA-2007-D-0369-2435 FDA None FDA-2007-D-0369 PSG_018891 - Draft Guidance on Clonidine Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:19:51   1 0 09000064b91df4ca
FDA-2007-D-0369-2453 FDA None FDA-2007-D-0369 PSG_021180 - Draft Guidance on Ethinyl Estradiol; Norelgestromin Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:25:18   1 0 09000064b91e0108
FDA-2007-D-0369-2439 FDA None FDA-2007-D-0369 PSG_019927 - Draft Guidance on Ketoconazole Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:21:03   1 0 09000064b91df4d2
FDA-2007-D-0369-2523 FDA None FDA-2007-D-0369 PSG_219016 - Draft Guidance on Rilpivirine Hydrochloride Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:51:25   1 0 09000064b91e01d9
FDA-2007-D-0369-2514 FDA None FDA-2007-D-0369 PSG_216962 - Draft Guidance on Foscarbidopa; Foslevodopa Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:48:20   1 0 09000064b91e01ba
FDA-2007-D-0369-2517 FDA None FDA-2007-D-0369 PSG_217370 - Draft Guidance on Acoltremon Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:49:14   1 0 09000064b91e01cd
FDA-2007-D-0369-2515 FDA None FDA-2007-D-0369 PSG_217202 - Draft Guidance on Landiolol Hydrochloride Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:48:39   1 0 09000064b91e01bc
FDA-2007-D-0369-2492 FDA None FDA-2007-D-0369 PSG_212304 - Draft Guidance on Donepezil Hydrochloride Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:40:33   1 0 09000064b91e0180
FDA-2007-D-0369-2503 FDA None FDA-2007-D-0369 PSG_215039 - Draft Guidance on Alpelisib Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:44:36   1 0 09000064b91e0196
FDA-2007-D-0369-2493 FDA None FDA-2007-D-0369 PSG_212306 - Draft Guidance on Selinexor Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:40:55   1 0 09000064b91e0182
FDA-2007-D-0369-2498 FDA None FDA-2007-D-0369 PSG_213953 - Draft Guidance on Testosterone Undecanoate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:42:31   1 0 09000064b91e018c
FDA-2007-D-0369-2472 FDA None FDA-2007-D-0369 PSG_050440 - Draft Guidance on Cephalexin Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:34:04   1 0 09000064b91e013a
FDA-2007-D-0369-2485 FDA None FDA-2007-D-0369 PSG_208171 - Draft Guidance on Ferric Derisomaltose Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:38:28   1 0 09000064b91e015e
FDA-2007-D-0369-2501 FDA None FDA-2007-D-0369 PSG_214522 - Draft Guidance on Tadalafil Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:44:01   1 0 09000064b91e0192
FDA-2007-D-0369-2491 FDA None FDA-2007-D-0369 PSG_212268 - Draft Guidance on Asenapine Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:40:16   1 0 09000064b91e017e
FDA-2007-D-0369-2477 FDA None FDA-2007-D-0369 PSG_204017 - Draft Guidance on Ethinyl Estradiol; Levonorgestrel Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:35:51   1 0 09000064b91e014e
FDA-2007-D-0369-2496 FDA None FDA-2007-D-0369 PSG_213004 - Draft Guidance on Amoxicillin; Omeprazole Magnesium; Rifabutin Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:41:55   1 0 09000064b91e0188
FDA-2007-D-0369-2434 FDA None FDA-2007-D-0369 PSG_018859 - Draft Guidance on Ribavirin Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:19:33   1 0 09000064b91df4c8
FDA-2007-D-0369-2431 FDA None FDA-2007-D-0369 PSG_017874 - Draft Guidance on Scopolamine Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:18:30   1 0 09000064b91df463
FDA-2007-D-0369-2449 FDA None FDA-2007-D-0369 PSG_020538 - Draft Guidance on Estradiol Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:24:10   1 0 09000064b91df4f6
FDA-2007-D-0369-2462 FDA None FDA-2007-D-0369 PSG_021588 - Draft Guidance on Imatinib Mesylate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:29:47   1 0 09000064b91e0125
FDA-2007-D-0369-2513 FDA None FDA-2007-D-0369 PSG_216675 - Draft Guidance on Perfluorohexyloctane Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:47:39   1 0 09000064b91e01b8
FDA-2007-D-0369-2510 FDA None FDA-2007-D-0369 PSG_216318 - Draft Guidance on Testosterone Cypionate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:46:43   1 0 09000064b91e01b1
FDA-2007-D-0369-2458 FDA None FDA-2007-D-0369 PSG_021351 - Draft Guidance on Oxybutynin Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:27:00   1 0 09000064b91e011d
FDA-2007-D-0369-2456 FDA None FDA-2007-D-0369 PSG_021306 - Draft Guidance on Buprenorphine Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:26:18   1 0 09000064b91e0119
FDA-2007-D-0369-2436 FDA None FDA-2007-D-0369 PSG_019081 - Draft Guidance on Estradiol Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:20:10   1 0 09000064b91df4cc
FDA-2007-D-0369-2455 FDA None FDA-2007-D-0369 PSG_021258 - Draft Guidance on Estradiol; Levonorgestrel Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:25:50   1 0 09000064b91e010c
FDA-2007-D-0369-2451 FDA None FDA-2007-D-0369 PSG_020831 - Draft Guidance on Formoterol Fumarate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:24:44   1 0 09000064b91e0104
FDA-2007-D-0369-2450 FDA None FDA-2007-D-0369 PSG_020612 - Draft Guidance on Lidocaine Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:24:27   1 0 09000064b91df4f8
FDA-2007-D-0369-2430 FDA None FDA-2007-D-0369 PSG_017628 - Draft Guidance on Tolmetin Sodium Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:18:11   1 0 09000064b91df461
FDA-2007-D-0369-2478 FDA None FDA-2007-D-0369 PSG_205395 - Draft Guidance on Cobicistat; Darunavir Ethanolate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:36:14   1 0 09000064b91e0150
FDA-2007-D-0369-2465 FDA None FDA-2007-D-0369 PSG_021986 - Draft Guidance on Dasatinib Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:31:13   1 0 09000064b91e012b
FDA-2007-D-0369-2483 FDA None FDA-2007-D-0369 PSG_208036 - Draft Guidance on Barium Sulfate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:37:51   1 0 09000064b91e015a
FDA-2007-D-0369-2468 FDA None FDA-2007-D-0369 PSG_022198 - Draft Guidance on Granisetron Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:32:47   1 0 09000064b91e0131
FDA-2007-D-0369-2470 FDA None FDA-2007-D-0369 PSG_022395 - Draft Guidance on Capsaicin Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:33:25   1 0 09000064b91e0135
FDA-2007-D-0369-2505 FDA None FDA-2007-D-0369 PSG_215352 - Draft Guidance on Phenylephrine Hydrochloride; Tropicamide Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:45:07   1 0 09000064b91e019a
FDA-2007-D-0369-2518 FDA None FDA-2007-D-0369 PSG_217514 - Draft Guidance on Dabrafenib Mesylate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:49:32   1 0 09000064b91e01cf
FDA-2007-D-0369-2487 FDA None FDA-2007-D-0369 PSG_210136 - Draft Guidance on Buprenorphine Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:39:03   1 0 09000064b91e016c
FDA-2007-D-0369-2502 FDA None FDA-2007-D-0369 PSG_214826 - Draft Guidance on Lorazepam Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:44:20   1 0 09000064b91e0194
FDA-2007-D-0369-2504 FDA None FDA-2007-D-0369 PSG_215110 - Draft Guidance on Glecaprevir; Pibrentasvir Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:44:51   1 0 09000064b91e0198
FDA-2007-D-0369-2474 FDA None FDA-2007-D-0369 PSG_202155 - Draft Guidance on Apixaban Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:34:51   1 0 09000064b91e013e
FDA-2007-D-0369-2499 FDA None FDA-2007-D-0369 PSG_214187 - Draft Guidance on Sofosbuvir; Velpatasvir Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:43:04   1 0 09000064b91e018e
FDA-2007-D-0369-2471 FDA None FDA-2007-D-0369 PSG_022549 - Draft Guidance on Loxapine Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:33:45   1 0 09000064b91e0138
FDA-2007-D-0369-2463 FDA None FDA-2007-D-0369 PSG_021590 - Draft Guidance on Clozapine Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:30:34   1 0 09000064b91e0127
FDA-2007-D-0369-2526 FDA None FDA-2007-D-0369 PSG_220073 - Draft Guidance on Apixaban Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:52:29   1 0 09000064b91e01f3
FDA-2007-D-0369-2519 FDA None FDA-2007-D-0369 PSG_218316 - Draft Guidance on Semaglutide Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:49:49   1 0 09000064b91e01d1
FDA-2007-D-0369-2521 FDA None FDA-2007-D-0369 PSG_218550 - Draft Guidance on Entrectinib Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:50:35   1 0 09000064b91e01d5
FDA-2007-D-0369-2524 FDA None FDA-2007-D-0369 PSG_219097 - Draft Guidance on Imatinib Mesylate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:51:42   1 0 09000064b91e01db
FDA-2007-D-0369-2525 FDA None FDA-2007-D-0369 PSG_219104 - Draft Guidance on Letermovir Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:52:13   1 0 09000064b91e01dd
FDA-2007-D-0369-2452 FDA None FDA-2007-D-0369 PSG_020870 - Draft Guidance on Estradiol; Norethindrone Acetate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:25:03   1 0 09000064b91e0106
FDA-2007-D-0369-2445 FDA None FDA-2007-D-0369 PSG_020310 - Draft Guidance on Ketoconazole Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:22:59   1 0 09000064b91df4ee
FDA-2007-D-0369-2433 FDA None FDA-2007-D-0369 PSG_018731 - Draft Guidance on Buspirone Hydrochloride Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:19:11   1 0 09000064b91df467
FDA-2007-D-0369-2437 FDA None FDA-2007-D-0369 PSG_019758 - Draft Guidance on Clozapine Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:20:28   1 0 09000064b91df4ce
FDA-2007-D-0369-2421 FDA None FDA-2007-D-0369 PSG_208564 Draft Guidance on Estradiol Other Guidance 2025-12-16T05:00:00Z 2025 12 2025-12-16T05:00:00Z   2025-12-16T20:30:49Z   1 0 09000064b90dccd3

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;